PeopleBio, Inc. (KOSDAQ:304840)

PeopleBio Statistics

Total Valuation

PeopleBio has a market cap or net worth of KRW 28.69 billion. The enterprise value is 34.73 billion.

Market Cap	28.69B
Enterprise Value	34.73B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

PeopleBio has 21.17 million shares outstanding. The number of shares has increased by 9.16% in one year.

Current Share Class	21.17M
Shares Outstanding	21.17M
Shares Change (YoY)	+9.16%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.46%
Owned by Institutions (%)	n/a
Float	18.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.16
PB Ratio	9.68
P/TBV Ratio	34.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.82
EV / Sales	11.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.41

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 3.46.

Current Ratio	0.76
Quick Ratio	0.35
Debt / Equity	3.46
Debt / EBITDA	n/a
Debt / FCF	-1.01
Interest Coverage	-4.96

Financial Efficiency

Return on equity (ROE) is -126.13% and return on invested capital (ROIC) is -44.22%.

Return on Equity (ROE)	-126.13%
Return on Assets (ROA)	-27.96%
Return on Invested Capital (ROIC)	-44.22%
Return on Capital Employed (ROCE)	-163.35%
Revenue Per Employee	66.64M
Profits Per Employee	-193.60M
Employee Count	47
Asset Turnover	0.14
Inventory Turnover	0.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.47% in the last 52 weeks. The beta is 0.50, so PeopleBio's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-72.47%
50-Day Moving Average	1,656.88
200-Day Moving Average	2,425.77
Relative Strength Index (RSI)	26.92
Average Volume (20 Days)	289,738

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PeopleBio had revenue of KRW 3.13 billion and -9.10 billion in losses. Loss per share was -418.99.

Revenue	3.13B
Gross Profit	678.28M
Operating Income	-9.77B
Pretax Income	-9.90B
Net Income	-9.10B
EBITDA	-8.05B
EBIT	-9.77B
Loss Per Share	-418.99

Balance Sheet

The company has 3.41 billion in cash and 10.26 billion in debt, giving a net cash position of -6.84 billion or -323.15 per share.

Cash & Cash Equivalents	3.41B
Total Debt	10.26B
Net Cash	-6.84B
Net Cash Per Share	-323.15
Equity (Book Value)	2.96B
Book Value Per Share	177.38
Working Capital	-3.88B

Cash Flow

In the last 12 months, operating cash flow was -10.04 billion and capital expenditures -158.61 million, giving a free cash flow of -10.20 billion.

Operating Cash Flow	-10.04B
Capital Expenditures	-158.61M
Free Cash Flow	-10.20B
FCF Per Share	-481.64

Margins

Gross margin is 21.66%, with operating and profit margins of -311.99% and -290.51%.

Gross Margin	21.66%
Operating Margin	-311.99%
Pretax Margin	-315.95%
Profit Margin	-290.51%
EBITDA Margin	-256.92%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PeopleBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.16%
Shareholder Yield	-9.16%
Earnings Yield	-31.72%
FCF Yield	-35.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 23, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 23, 2023
Split Type	Forward
Split Ratio	1.2

Scores

PeopleBio has an Altman Z-Score of -4.61. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.61
Piotroski F-Score	n/a